apathy (indifference)
Jump to navigation
Jump to search
Introduction
Indifference. A lack of interest in one's environment, including social interactions.
Etiology
Pathology
- disruptions of circuits regulating basic drives:
- sexual satisfaction
- food
- curiosity
- pleasure
- disrupted circuits include
- mesolimbic system
- mesocortical dopaminergic circuits
Clinical manifestations
- reduction in psychomotor activity
- often perceived as a personality change by family
- affects ADLs beyond the level of cognitive impairment
Management
- little evidence to support specific therapy[3][4]
- cholinesterase inhibitors may be of some benefit[4]
- methylphenidate may be of benefit in community-dwelling elderly with mild to moderate Alzheimer's disease[5][6]
- may improve motivation, cognition, mood, functioning, & caregiver burden
- does not affect patients' function or quality of life[6]
More general terms
References
- ↑ Stedman's Medical Dictionary 27th ed, Williams & Wilkins, Baltimore, 1999
- ↑ Principles of Neurology, 4th ed, Adams RD & Victor M (eds) McGraw-Hill, Inc, New York, 1989
- ↑ 3.0 3.1 Geriatric Review Syllabus, 7th edition Parada JT et al (eds) American Geriatrics Society, 2010
Geriatric Review Syllabus, 8th edition (GRS8) Durso SC and Sullivan GN (eds) American Geriatrics Society, 2013 - ↑ 4.0 4.1 4.2 Berman K, Brodaty H, Withall A, Seeher K Pharmacologic treatment of apathy in dementia. Am J Geriatr Psychiatry. 2012 Feb;20(2):104-22. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/21841459
- ↑ 5.0 5.1 Padala PR, Padala KP, Lensing SY et al. Methylphenidate for apathy in community-dwelling older veterans with mild Alzheimer's disease: A double-blind, randomized, placebo-controlled trial. Am J Psychiatry 2017 Sep 15 PMID: https://www.ncbi.nlm.nih.gov/pubmed/28945120
- ↑ 6.0 6.1 6.2 George J Stimulant Reduces Apathy in Alzheimer's Disease Twice daily methylphenidate showed modest effect size. MedPage Today September 27, 2021 https://www.medpagetoday.com/neurology/alzheimersdisease/94722
Mintzer J, Lanctot KL, Scherer RW et al Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease. The ADMET 2 Randomized Clinical Trial. JAMA Neurol. Published online September 27, 2021. PMID: https://www.ncbi.nlm.nih.gov/pubmed/34570180 https://jamanetwork.com/journals/jamaneurology/fullarticle/2784538
Fredericks C Methylphenidate for Apathy in Alzheimer Disease - Why Should We Care? JAMA Neurol. Published online September 27, 2021 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34570178 https://jamanetwork.com/journals/jamaneurology/fullarticle/2784541